http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-27140-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_810e5f0f5b6d384a3a17cc3c005fd4ee |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08J9-00 |
| filingDate | 2002-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31e828bb3184760f07b3652cf524d007 |
| publicationDate | 2002-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UY-27140-A1 |
| titleOfInvention | VEHICLE WITH SOLID FIBRINOGEN AND SOLID THROMBIN. |
| abstract | The present invention relates to a solid composition useful for tissue bonding, tissue sealing and hemostasis, which essentially consists of a) a vehicle having at least one of the following physical properties: modulus of elasticity in the range of 5 -100 N / cm, density of 1-10mg / cm3, chamber diameter greater than 0.75 mm and less than 4mm and / or having an average chamber diameter less than 3mm and evenly distributed and fixed on said vehicle, b) fibrinogen solid, and c) solid thrombin. The carrier is a biodegradable polymer such as a polyhyaluronic acid, polyhydroxylated acid, for example lactic acid, gulocolic acid, hydroxybutanoic acid, a cellulose, gelatin or collagen, such as a collagen sponge consisting essentially of type I collagen fibers. The fibrinogen and thrombin are preferably transgenic or recombinant human. In a preferred embodiment, the composition does not comprise any antifibrinolytic agent such as aprotinin, e-aminocaproic acid or alpha2-antiplasmin. |
| priorityDate | 2001-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.